Proactive Investors - Run By Investors For Investors

PreveCeutical Medical progressing well with fingerprinting cannabis strains

The group has applied its protocol and optimised cannabinoid extraction from two cannabis strains
PreveCeutical Medical progressing well with fingerprinting cannabis strains
PreveCeutical is a health sciences firm developing options for preventive and curative therapies

PreveCeutical Medical Inc (TSX:PREV) (OTCQB:PRVCF) reported good progress in  its soluble gel drug delivery research and development (R&D) program.

It has applied its protocol and optimised cannabinoid extraction from two  cannabis strains provided by the company's licensed producer partner Aurora Cannabis Inc.

Preveceutical's chief research officer Dr. Harendra Parekh said: "This is an important verification of our efforts in reproducibly extracting and identifying cannabinoid and THC-rich fractions from plant material, leading to distinct fingerprints for a given strain."

"We are excited with how the fingerprinting of the cannabis strains is progressing," added PreveCeutical's chairman, chief executive and president Stephen Van Deventer.

"With the CBD Sol-gel formulations and applicator development on track, this brings us one step closer to getting the Sol-gel nose-to-brain delivery system to market."

PreveCeutical said it aims to fingerprint two more cannabis strains by 2019, which will bring the total number of distinct fingerprinted cannabis strains in its target cannabinoid concentration range to five.

The company aims to use the fingerprints to generate a range of cannabinoid-based Sol-gel formulations each with a distinct, well-defined cannabinoid composition profile.

View full PREV profile View Profile

PreveCeutical Medical Inc Timeline

Related Articles

1542204301_heart.jpg
November 14 2018
The goal of the program is to extend the visualization extracted from 2D ultrasound images and visualize 4D images
Nemaura Medical Inc CEO Dr Faz Chowdhury
November 05 2018
The medtech company is eying explosive growth with sugarBEAT, on the cusp of launching in the UK, followed by the rest of Europe in 2018
glasshouse
January 08 2019
Its plans to become a first-mover seed-to-consumer business here in the UK, following the model pioneered in Canada
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use